Continuous Dual Aspiration Technique With Zoom System for Stroke
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorImperative Care, Inc.
About this trial
This study is designed to evaluate the effectiveness, safety and clinical performance of ADAPT 2.0, first-line aspiration neurothrombectomy with Zoom System with Continuous Dual Aspiration Technique (CDAT).
Eligibility criteria
Qualifiers
Subject is ≥ 18 years of age
Subject or legally authorized representative has provided written informed consent prior to any study-specific procedures and no later than 72 hours after the index procedure
Pre-stroke mRS 0-2
Subject is undergoing or has undergone an aspiration thrombectomy using the Zoom System with Continuous Dual Aspiration Technique (CDAT) as the first line device within its intended use
Disqualifiers
Subjects with a life expectancy of less than 6 months
Female subject who is known to be pregnant at time of admission
Any intracranial hemorrhage in the qualifying head CT or MRI
Presence of tandem internal carotid artery occlusion, multiple occlusion locations (e.g., cavernous ICA and M1, separate M2 occlusions, etc.), or occlusions in multiple territories (e.g., MCA and ACA, bilateral, etc.).
Trial design
Treatments tested in this trial
- Zoom System
Treatment groups
750 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov